Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis.
暂无分享,去创建一个
Takao Shimizu | H. Shindou | H. Karasuyama | Y. Minegishi | Y. Tsujimura | K. Mukai | K. Obata | Y. Kawano | H. Nishikado | M. Yoshida
[1] F. Finkelman. Anaphylaxis: lessons from mouse models. , 2007, The Journal of allergy and clinical immunology.
[2] H. Karasuyama,et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. , 2007, Blood.
[3] Zhiqian Yu,et al. Induction of serum IL‐18 with Propionibacterium acnes and lipopolysaccharide in phagocytic macrophage‐inactivated mice , 2007, Journal of leukocyte biology.
[4] F. Simons,et al. Risk assessment in anaphylaxis: current and future approaches. , 2007, The Journal of allergy and clinical immunology.
[5] J. Kinet,et al. New developments in FcεRI regulation, function and inhibition , 2007, Nature Reviews Immunology.
[6] 朱丽琳,et al. Anaphylaxis , 2006 .
[7] F. Finkelman,et al. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking , 2006 .
[8] D. Hepner,et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. , 2006, The Journal of allergy and clinical immunology.
[9] C. Chen,et al. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.
[10] K. Hirokawa,et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. , 2005, Immunity.
[11] S. Galli. Pathogenesis and management of anaphylaxis: current status and future challenges. , 2005, The Journal of allergy and clinical immunology.
[12] W. Paul,et al. Basophils Produce IL-4 and Accumulate in Tissues after Infection with a Th2-inducing Parasite , 2004, The Journal of experimental medicine.
[13] D. Voehringer,et al. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. , 2004, Immunity.
[14] A. Guttormsen,et al. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia , 2003, Acta anaesthesiologica Scandinavica.
[15] T. Kuijpers,et al. Regulation and kinetics of platelet‐activating factor and leukotriene C4 synthesis by activated human basophils , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[16] S. Plevy,et al. The Incidence and Management of Infusion Reactions to Infliximab: A Large Center Experience , 2003, American Journal of Gastroenterology.
[17] Calman Prussin,et al. IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.
[18] R. Lockey,et al. Anaphylaxis: a review of causes and mechanisms. , 2002, The Journal of allergy and clinical immunology.
[19] P. Lieberman,et al. Histamine and antihistamines in anaphylaxis. , 2002, Clinical allergy and immunology.
[20] L. Schwartz. Mast cells and basophils. , 2002, Clinical allergy and immunology.
[21] F. Finkelman,et al. Pathways of anaphylaxis in the mouse. , 2002, The Journal of allergy and clinical immunology.
[22] Franco H Falcone,et al. The human basophil: a new appreciation of its role in immune responses. , 2000, Blood.
[23] H. Shindou,et al. Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. , 2000, Biochemical and biophysical research communications.
[24] R. Coffman,et al. Cutting edge: mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12. , 1999, Journal of immunology.
[25] Jae Seung Park,et al. Immunoglobulin E–dependent Active Fatal Anaphylaxis in Mast Cell–deficient Mice , 1998, The Journal of experimental medicine.
[26] J. Park,et al. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. , 1997, Journal of immunology.
[27] S. Galli,et al. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. , 1997, The Journal of clinical investigation.
[28] S. Galli,et al. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. , 1997, The Journal of clinical investigation.
[29] R. Schmidt,et al. Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice , 1996 .
[30] K. Kumagai,et al. Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor , 1995, British journal of pharmacology.
[31] N. Van Rooijen,et al. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.
[32] P. Leder,et al. Active anaphylaxis in IgE-deficient mice , 1994, Nature.
[33] C. Hirshman,et al. High-titer protamine-specific IgG antibody associated with anaphylaxis: report of a case and quantitative analysis of antibody in vasectomized men. , 1993, Anesthesiology.
[34] A. Arimura,et al. Active and passive cutaneous anaphylaxis in WBB6F1 mouse, a mast cell-deficient strain. , 1990, Immunological investigations.
[35] C. Hirshman,et al. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. , 1989, The New England journal of medicine.
[36] P. Braquet,et al. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. , 1987, Journal of immunology.
[37] P. Cammarata,et al. Anaphylaxis in mast cell-deficient mice. , 1984, The Journal of investigative dermatology.
[38] M. Devey,et al. Immunoglobulin Class and Subclass Distribution of Dextran‐Reactive Antibodies in Human Reactors and Non Reactors to Clinical Dextran , 1982, Allergy.
[39] L. McManus,et al. Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[40] Y. Kitamura,et al. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. , 1978, Blood.
[41] J. Benveniste,et al. Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils , 1974, Nature.
[42] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[43] Michael Schwenk,et al. Anaphylaxis , 1919, The Indian medical gazette.
[44] P. Kam,et al. : 4 , 1898, You Can Cross the Massacre on Foot.
[45] 小島 利之. Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-independent manner , 2008 .
[46] H. Brühl,et al. Identification of Antigen-Capturing Cells as Basophils , 2004 .
[47] D. Metcalfe,et al. 4. IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.
[48] R. Schmidt,et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. , 1996, Immunity.
[49] L. Lichtenstein,et al. CURRENT CONCEPTS : ANAPHYLAXIS , 1991 .
[50] F. Snyder. Platelet-Activating Factor and Related Lipid Mediators , 1987, Springer US.
[51] G. Köhler,et al. Biological activities of antitrinitrophenyl and antidinitrophenyl mouse monoclonal antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Wabl,et al. Thirteen hybridomas secreting hapten‐specific immunoglobulin E from mice with Iga or Igb heavy chain haplotype , 1981, European journal of immunology.
[53] 박귀태,et al. A Type 2 Diabetes–Associated Functional Regulatory Variant in a Pancreatic Islet Enhancer at the ADCY5 Locus , 2017, Diabetes.